[Skip to Content]
[Skip to Content Landing]
Article
April 9, 1955

CORRELATION OF FIELD SIZE AND CANCEROCIDAL DOSE IN X-RAY TREATMENT OF SKIN CANCER

Author Affiliations

Denver

Clinical Professor of Radiology, University of Colorado Medical Center (Dr. Allen); and Associate Professor of Radiology, University of Colorado Medical Center (Dr. Freed).

JAMA. 1955;157(15):1271-1274. doi:10.1001/jama.1955.02950320001001
Abstract

There has been recent increase of interest among radiologists in protraction of multiple roentgen doses (fractionation) in the treatment of cancer. This has been generated in part by Strandqvist's1 study of this subject in skin cancer and in Andrews'2 and Ahlbom's3 papers discussing Strandqvist's work. We have noticed a gap in the teaching on this subject that we believe should be filled. This is a failure to stress the importance of the size of the field irradiated in skin cancer as related to the maximum dose (fractionated or massive) that can give a good cosmetic result. We hope at this time to fill as much of the gap as possible and believe our dosage charts will express our experience in practical terms. We wish especially to assist the younger radiologists in computing safe cancerocidal roentgen dosage for patients with skin cancer by correlating field size with total

First Page Preview View Large
First page PDF preview
First page PDF preview
×